Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FD4WL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,043
Award facts
- Contract value 100% obligated
- $10,042.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $10,043 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 266 mg/20 mL vials of Exparel. The contract utilizes firm fixed-price pricing with no set-aside designation and is scheduled for ultimate completion by August 7, 2025. This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facility needs worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders from the DLA for branded and generic prescription drugs, biologics, and medical consumables. Exparel, a liposomal bupivacaine product used for local anesthesia and pain management, represents the type of specialty pharmaceutical product the contractor regularly delivers to Department of Defense healthcare facilities. The company's sustained contract performance and woman-owned small business status have positioned it as a preferred vendor for DLA pharmaceutical procurement, with this delivery order exemplifying the routine replenishment of medical supplies across the military health system.
Quick answers
Who was awarded contract SPE2DB25FD4WL?
SPE2DB25FD4WL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 17, 2025.
How much is contract SPE2DB25FD4WL worth?
The government has obligated $10,043 on SPE2DB25FD4WL.
Is contract SPE2DB25FD4WL an order under another contract?
Yes. SPE2DB25FD4WL is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4WL competed?
The extent of competition for SPE2DB25FD4WL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award